| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
22,101 |
14,092 |
$1.16M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,743 |
11,377 |
$845K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
8,318 |
4,666 |
$652K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
1,871 |
1,090 |
$452K |
| 99233 |
Prolong inpt eval add15 m |
3,752 |
1,879 |
$440K |
| 96411 |
|
5,224 |
2,908 |
$321K |
| J9271 |
Injection, pembrolizumab, 1 mg |
57 |
40 |
$297K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,383 |
1,571 |
$296K |
| 36593 |
|
13,167 |
7,925 |
$293K |
| 96417 |
|
3,233 |
2,147 |
$224K |
| 96415 |
|
4,541 |
2,708 |
$206K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,318 |
1,970 |
$179K |
| 99215 |
Prolong outpt/office vis |
1,578 |
1,407 |
$135K |
| 99223 |
Prolong inpt eval add15 m |
1,159 |
1,078 |
$116K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
31,071 |
17,842 |
$99K |
| Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg |
56 |
37 |
$93K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
6,682 |
3,380 |
$75K |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
218 |
116 |
$65K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,634 |
2,927 |
$56K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
6,216 |
3,205 |
$38K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,266 |
754 |
$29K |
| 96401 |
|
1,058 |
640 |
$24K |
| J7050 |
Infusion, normal saline solution, 250 cc |
5,884 |
3,414 |
$21K |
| 82950 |
|
9,121 |
5,240 |
$18K |
| 99000 |
|
4,881 |
3,983 |
$17K |
| J9171 |
Injection, docetaxel, 1 mg |
26 |
13 |
$14K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
5,621 |
3,014 |
$12K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
3,513 |
2,109 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
5,641 |
3,867 |
$9K |
| 99205 |
Prolong outpt/office vis |
63 |
63 |
$9K |
| 99245 |
|
90 |
89 |
$9K |
| 90686 |
|
677 |
674 |
$8K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
159 |
151 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
153 |
105 |
$5K |
| 90670 |
|
56 |
56 |
$5K |
| 90732 |
|
59 |
59 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
138 |
136 |
$2K |
| 90677 |
|
12 |
12 |
$2K |
| 96367 |
|
37 |
26 |
$1K |
| 36415 |
Collection of venous blood by venipuncture |
1,430 |
1,216 |
$1K |
| 85610 |
|
596 |
436 |
$1K |
| J9045 |
Injection, carboplatin, 50 mg |
29 |
24 |
$682.15 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
315 |
192 |
$645.68 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
38 |
28 |
$615.86 |
| 90756 |
|
69 |
68 |
$557.07 |
| 99406 |
|
44 |
44 |
$492.26 |
| 90658 |
|
18 |
18 |
$317.03 |
| 90656 |
|
19 |
19 |
$98.69 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
17 |
17 |
$87.05 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
27 |
24 |
$34.41 |
| G0008 |
Administration of influenza virus vaccine |
64 |
64 |
$0.00 |